NEWS RELEASE

Clovis Oncology to Announce First Quarter 2019 Financial Results and Host Webcast Conference Call on May 7

4/24/2019

BOULDER, Colo.--(BUSINESSWIRE)-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its $rst quarter 2019 nancial results on Tuesday, May 7, 2019, before the open of the U.S. 5nancial markets. Clovis' senior management

will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the company's results in greater detail.

The conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.

Conference Call Details

Clovis will hold a conference call to discuss rst quarter 2019 results on Tuesday, May 7, at 8:30 a.m. ET. The conference call will be simultaneously webcast on the Company's web site at www.clovisoncology.com, and archived for future review. Dial-in numbers for the conference call are as follows: US participants 877.698.7048, International participants 647.689.5448, conference ID: 8567356.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at speciQc subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to the population that is most likely to beneNt from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional oWce locations in the U.S. and Europe.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190424005856/en/

1

Clovis Investor Contacts:

Anna Sussman, 303.625.5022 asussman@clovisoncology.com

Breanna Burkart, 303.625.5023 bburkart@clovisoncology.com

Source: Clovis Oncology, Inc.

2

Attachments

  • Original document
  • Permalink

Disclaimer

Clovis Oncology Inc. published this content on 24 April 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 24 April 2019 20:12:20 UTC